Multidrug resistance protein 2-mediated estradiol-17βcuronide transport potentiation: In vitro-in vivo correlation and species specificity

K. Herédi-Szabó, H. Glavinas, E. Kis, D. Méhn, G. Báthori, Z. Veres, L. Kóbori, O. Von Richter, K. Jemnitz, P. Krajcsi

Research output: Contribution to journalArticle

24 Citations (Scopus)


Multidrug resistance protein 2 (MRP2) is a multispecific organic anion transporter expressed at important pharmacological barriers, including the canalicular membrane of hepatocytes. At this location it is involved in the elimination of both endogenous and exogenous waste products, mostly as conjugates, to the bile. Estradiol-17β-D-glucuronide (E217β G), a widely studied endogenous substrate of MRP2, was shown earlier to recognize two binding sites of the transporter in vesicular transport assays. MRP2 modulators (substrates and nonsubstrates) potentiate the transport of E217βG by MRP2. We correlated data obtained from studies of different complexities and investigated the speciespecific differences between rat and human MRP2-mediated transport. We used vesicular transport assays, sandwich-cultured primary hepatocytes, and in vivo biliary efflux in rats. Our results demonstrate that the rat Mrp2 transporter, unlike the human MRP2, transports E217βG according to Michaelis-Menten type kinetics. Nevertheless, in the presence of modulator drugs E217β Gtransport mediated by the rat transporter also shows cooperative kinetics as potentiation of E217β G transport was observed in the vesicular transport assay. We also demonstrated that the potenti-ation exists both in rat and in human hepatocytes and in vivo in rats.

Original languageEnglish
Pages (from-to)794-801
Number of pages8
JournalDrug Metabolism and Disposition
Issue number4
Publication statusPublished - Apr 1 2009


ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Cite this